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joints involved, affected site, age of patients, and occupational activities.
According with the EULAR recommendations three treatment modali-
ties can been proposed: non-pharmacological, pharmacological, and
surgical. In many patients these modalities should be combined,
tailored to individual needs and risk factors.
Although non-pharmacological therapies are important in the
management of HOA, high quality evidence is lacking. The exercise
seems useful when combined with education and joint protection.
Advice regarding the use of electrotherapy, thermotherapy, ultrasound,
TENS or laser therapy is conﬂicting, mainly due to the lack of eligible
studies. So, their inclusion in recommendations relies mainly on
consensus methods and expert opinion.
As regard as the pharmacological therapy, the most realistic aim is the
pain relief, due to limited evidence of reliable efﬁcacy in modifying
disease activity by drugs.
Among analgesics, paracetamol is considered as the ﬁrst choice and, if
successful, the preferred for long term, although evidence supporting
its use in HOA are few. In mild to moderate pain and when not many
joints are affected, topical treatments are a good option for many
aspects, including the cost effectiveness. If paracetamol or topical
NSAIDs are insufﬁcient, then the addition of opioid analgesics should be
considered, although the evidence supporting its use in HOA is poor.
In patients who respond inadequately to paracetamol or topical treat-
ments, oral NSAIDs or COX-2 inhibitor should be used in substitution or
in addition, possibly at lowest effective dose for the shortest period of
time and taking into account individual patient risk factors, including
age and comedications.
Intra-articular (IA) long-acting corticosteroid is effective for painful
ﬂares of OA, especially trapeziometacarpal joint (TMC) OA and so, it
should be considered as an adjunct to core treatment for the relief of
moderate to severe pain in people with HOA. There are contrasting
opinions on the usefulness of IA hyaluronan (HA) in all existing
recommendations. However, in two recent trials it seems more
favourable than IA steroids.
The most studied SYSADOA in HOA has been the chondroitin sulphate
(CS). In the recent 6 months RCT performed by Gabay, decrease in global
hand pain and improvement of hand function were signiﬁcantly more
pronounced in the CS than in the placebo group. This drug was also
evaluated as DMOAD, in two independent trials comparing CS with
placebo and chondroitin polysulphate (CPS) with placebo in erosive
HOA (EHOA). The results showed that over a 3-year period CS was no
more beneﬁcial than placebo, whereas CPS was more effective than
placebo in preventing radiographic progression.
The EHOA is the HOA subset deserving main attention by new treat-
ment strategies, due to its severity and poor outcome. So, anti-cytokines
biologic agents have been tested in some pilot studies using s.c. ana-
kinra, humira and IA inﬂiximab, with good results, as also conﬁrmed by
the ﬁrst RCT recently performed by Verbruggen, with Humira.
Surgery is uncommonly performed in HOA, and evidence for its effec-
tiveness is lacking. However, for HOA at the base of the thumb, evidence
does support effectiveness of surgical therapy when conventional
therapies have failed. These surgical interventions include tra-
peziectomy, arthrodesis, osteotomy, ligament reconstruction, and joint
replacement. Surgery for areas other than the thumb base is not yet
widely available as a treatment option.
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PATHOPHYSIOLOGY OF POST-TRAUMATIC ARTHRITIS
S.R. Goldring. Hosp. for Special Surgery, New York, NY
Epidemiologic studies have ﬁrmly established the association between
acute joint injury and the increased risk for the subsequent develop-
ment and progression of osteoarthritis (OA). All of the joint tissues are
susceptible to traumatic injury, including the ligaments, menisci,
articular cartilage and periarticular bone, and to some extent the
natural history of the OA process is related to the magnitude, site and
extent of the initial joint injury. However, independent of the speciﬁc
site or target tissue affected by the injury, all of the joint tissues are
eventually affected by the osteoarthritic process. Multiple mechanisms
contribute to the pathogenesis of the osteoarthritic changes after a joint
injury and although much of the attention has focused on the adverse
effects of increased joint instability and altered joint mechanics, there is
evidence that the pathogenic process in many individual is in fact
attributable to the initial acute-impact injury to the articular surfaceand in some instances the adjacent subchondral bone. These impact
injuries not onlymay disrupt the structural integrity of these tissues but
also can induce acute as well as chronic adverse effects on the survival
and functional activities of the resident cell populations. With respect to
the articular cartilage these changes include de-regulation of the
synthetic and reparative capacity of the chondrocytes, as well as the
release of potent biological mediators such as reactive oxygen species,
proteolytic enzymes and proinﬂammatory cytokines. In addition,
although OA generally is not viewed as an inﬂammatory form of
arthritis there is evidence that synovial inﬂammation not only
contributes to joint symptoms but also plays a role in the structural and
functional deterioration of joint tissues in both post traumatic OA and
other forms of OA. De-regulated chondrocyte function and the release
of biologically active chondrocyte-derived factors or products from the
cartilage extracellular matrix have been implicated in the synovial
inﬂammation, and many of the synovial derived products in turn may
adversely affect the homeostasis of the adjacent articular cartilage and
bone. Studies have shown that the risk factors for OA initiation and
progression in patients with post traumatic OA are similar to those for
idiopathic OA in that systemic host factors and local biomechanical
factors interact and that obesity, female gender, and pre-existing early-
stage OA contribute signiﬁcantly to adverse radiographic and clinical
outcomes. There remains uncertainty regarding the long-term beneﬁt
of surgical interventions with respect to prevention or slowing the
development of OA, and there is a critical need for rigorous clinical and
laboratory studies to deﬁne the factors that are responsible for joint
deterioration in patients with traumatic joint injuries and for assessing
the impact of interventions on the status of joint tissues and function.
I-24
REGENERATIVE MEDICINE APPROACHES FOR THE TREATMENT AND
PREVENTION OF OSTEOARTHRITIS
C. De Bari. Univ. of Aberdeen, Aberdeen, United Kingdom
Osteoarthritis (OA) is the most common joint disease and is estimated
to affect more than 8 million people in the UK alone. Underlying the
disease is a loss of the normal homeostasis of the joint with progressive
breakdown of tissues including articular cartilage and subchondral
bone leading to end-stage joint destruction and failure. For the patient,
quality of life is reduced because of the loss of movement and joint pain
increases to become continuous, even at rest. OA is deﬁned as a complex
disorder with three groups of risk factors: genetic, constitutional (e.g.,
ageing and obesity) and local (e.g., secondary to mechanical load and
joint injury).
Current treatment options are limited to analgesia and physiotherapy,
and to prosthetic joint replacement for end-stage disease. Management
of OA is aimed at alleviating symptoms but current treatments do not
address the disease process itself. There is an unmet need to develop
new treatment options that could halt disease progression, at an early
stage. In this respect, regenerative medicine (including tissue engi-
neering) offers the potential for a long-term solution via biological
regeneration, repair or replacement of the degenerate joint tissues.
Pioneering approaches to biological joint resurfacing include autolo-
gous chondrocyte implantation and marrow stimulation techniques
such as microfracture. The lecture will outline possible cell-based
therapy interventions to treatment or prevention of OA, with a partic-
ular focus onto secondary post-traumatic OA. Exogenous (autologous or
allogeneic) stem cells could be injected intra-articularly into affected
joints or implanted locally into a damaged tissue, for instance into
a defect of the articular cartilage, either in suspension or in combination
with a biomaterial. Stem cells could be transplanted either after culture-
expansion or as minimally manipulated, e.g. immediately after their
puriﬁcation from their tissue sources. However, important ongoing
issues relate to identity characterization and potency assessment of the
different types of stem cells and how they can be bioprocessed with
consistency and implanted for effective repair of the damaged joint
surface and degenerate joint tissues. Using stem cells in combination
with biomaterials, there is also the potential to create ex vivo biological
joint tissues such as menisci, or even a fully biological prosthesis.
Opportunities and challenges from a research perspective will be
discussed.
The arthritic joint also demonstrates apparent repair mechanisms that
can result in aberrant formation of cartilage and bone in the form of
chondro-osteophytes. This presumes existence of endogenous stem
cells in the joint. In this regard, we recently provided data on the
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chymal stem cells (MSCs) in the adult mouse knee joint synovium in
vivo. Currently, we are investigating the role of the endogenous MSCs in
the mechanisms underlying joint homeostasis as well as development
and progression of OA. The existence of functional MSC niches in the
adult joint opens up unprecedented opportunities for pharmacological
interventions by using medications that would target MSC niches and
related reparative signalling pathways to activate and modulate
intrinsic mechanisms of joint tissue regeneration. It is hoped that such
interventions may halt progression of OA or even prevent OA, while
restoring an effective homeostatic joint.
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YEAR IN REVIEW: CLINICAL
M.C. Hochberg. Univ. of Maryland, Baltimore, MD
Purpose: To review important articles published since the 2011 World
Congress of Osteoarthritis in the clinical and epidemiologic areas of
osteoarthritis (OA).
Methods: A systematic review of the literature was conducted. Medline
was searched through PubMed using the search terms “osteoarthritis
[ti]”. The search was restricted to English language, humans and all
adults age 19+ for the time period “last 180 days.” The search was
further limited by adding the word “clinical.”
Results: A total of 118 and 42 titles were identiﬁed in the initial and
restricted searches, respectively. The author reviewed the titles of the
42 articles and chose several that will be brieﬂy discussed during his
presentation.
Conclusions: There have been some important clinical and epidemio-
logic studies of OA that have been published since the 2011 World
Congress of OA. The searchwill be updated in theweeks just prior to the
2012World Congress in order to identify and highlight newer literature.
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OSTEOARTHRITIS YEAR IN REVIEW: REHABILITATION AND
OUTCOMES
E.M. Roos, C. Juhl. Sports Sci. and Clinical Biomechanics, Odense M,
Denmark
Purpose: This review highlights seminal publications of rehabilitation
and outcomes in osteoarthritis (OA) of the hip or knee.
Methods: A systematic literature search was performed in Medline
from July 2011 up to January 24, 2012 using the terms ‘osteoarthritis,
knee’, ‘osteoarthritis, hip’ rehabilitation, physical therapy, exercise and
preoperative intervention, outcomes. Trials evaluating rehabilitation
interventions were included if they were randomized trials (RCT) or
systematic reviews. Surgical interventions and pharmacology studies
were excluded unless they included evaluation of a rehabilitation
intervention. Outcome studies were included if they contributed
methodologically to advancing outcome measurement.
Results: The literature search identiﬁed 259 hits. 21 publications were
selected and reviewed that related to cost-effectiveness of non-phar-
macological and non-surgical interventions, interventions evaluating
care processes, decision making and information, weight loss, exercise
(balance training, walking, neuromuscular, combined with self-
management, aquatic vs. landbased, adherence), bracing, whole body
vibration, short wave therapy and acupuncture/moxibustion.
One systematic review provided limited evidence for the cost-effec-
tiveness of conservative treatments for the management of hip and/or
knee osteoarthritis. This was supported by a large RCT showing patients
randomized to exercise and self-management having a high probability
of being cost-effective at 30 months.
Another meta-analysis found low to moderate evidence from mostly
small RCTs demonstrating that pre-operative interventions, particularly
exercise, reduce pain for patients with hip and knee osteoarthritis prior
to joint replacement, and exercise with education programs may
improve activity after hip replacement.
The increased focus on care strategies, decision-making instruments
and patient information in osteoarthritis treatment was highlighted by
several publications. A consensus-based strategy provided a framework
for health care providers and patients with hip or knee osteoarthritis to
discuss the optimal timing of the various treatment options. An
audiovisual patient decision aid aiming at changing disadvantageous
beliefs and encourage physical activity was associated with a small
effect.The studies on exercise added information on treatment effect of
important aspects such as type, combined treatments, and adherence to
exercise.
A single high quality RCT found low-energy-diet induced weight loss to
relieve pain also at one year and lead to independent losses of leg
muscle tissue and strength, indicating the need for exercise in
conjunction with low-energy-diet induced weight loss programs.
A systematic review failed to provide conclusive evidence for the effec-
tiveness of moxibustion (warm acupuncture) compared with drug
therapy in rheumatic conditions. The total number of RCTs included in
this review and their methodological quality were low. An RCT found
moxibustion combined with intra-articular injection of sodium hyalur-
onate to be more effective than intra-articular injection of sodium hya-
luronate alone. A secondaryanalysis of 10 000patients included in oneof
four RCTs for one of four chronic pain problems, including hip or knee
osteoarthritis, found that age, education, duration of illness, baseline
pain, and some concomitant diseases predicted treatment outcome in
both groups (routine care with or without acupuncture). Patients'
characteristics that enlarged the acupuncture effect were being female,
living in a multi-person household, failure of other therapies before the
study, and former positive acupuncture experience.
A single high quality RCT among persons with symptomatic lateral PF
OA found the effects of a speciﬁc realigning PF brace not to be of clinical
or statistical signiﬁcance.
One RCT found pulsed shortwave treatment to be an effective method
for pain relief and improvement of function and quality of life in the
short term in women with knee OA.
The 16 outcomes papers considered relevant did not add signiﬁcantly to
current knowledge.
Conclusion: The current clinical focus on non-pharmacological and
non-surgical treatment of hip or knee OA translates into research
ﬁndings that increasingly are included in meta-analysis improving the
evidence level for non-pharmacological and non-surgical treatments in
hip or knee OA. Information, exercise and weight loss are supported as
ﬁrst line treatments and as adjunctive treatments prior to surgery.
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YEAR IN REVIEW – BIOLOGY
P.M. van der Kraan. Radboud Univ., Med. Ctr., Nijmegen, Netherlands
An overview will be given on selected topics that have advanced our
understanding of the (patho)biology of osteoarthritis. More and more it
becomes clear that osteoarthritis is not a cartilage-onlydisease but that all
joint tissues are involved and contribute to the overall disease process.
Osteoarthritis is an afﬂiction of the whole joint. In addition to cartilage,
attention will be paid to other tissues such as the synovium. The role of
cellular communication, inﬂammatory mediators, for instance compo-
nents of the complement system, and the role of miRNAwill be addressed.
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YEAR IN REVIEW: BIOMARKERS
A. Mobasheri. Univ. of Nottingham, Sutton Bonington, United Kingdom
Purpose: Biomarkers have the capacity to detect cartilage degradation
in degenerative joint diseases such as osteoarthritis (OA). They can
provide useful diagnostic information by reﬂecting disease relevant
biological activity in the joint and predict the course of disease
progression. In addition, they can serve as surrogate endpoints in the
drug discovery process. The “Year in Review” Plenary Session at the end
of the World Congress on Osteoarthritis is becoming a well-established
tradition. It provides a unique opportunity to build on the reviews from
the previous two years and summarize the key published papers related
to OA biomarkers. This presentation reviews the biomarker papers
published between the OARSI 2011 Congress held from 15–18
September 2011 in San Diego, California and the OARSI 2012 meeting,
which will be held from 26–29 April 2012 in Barcelona, Spain.
Methods: The PubMed/MEDLINE and SciVerse Scopus bibliographic
databases were searched using the following keywords: ‘biomarker’
and ‘osteoarthritis’. The PubMed/MEDLINE literature search was con-
ducted using the Advanced Search Builder function (http://www.ncbi.
nlm.nih.gov/pubmed/advanced) and speciﬁcally focused on the eight
months between the 2011 and 2012 meetings.
Results: Approximately thirty-two new OA biomarker papers were
published at the time this abstract was written (February 14, 2012). It is
estimated that ﬁfty papers will be published by April 2012. Some of
